CHD
34
7
SYF
78
7
MA
60
5
GE
60
5
NEE
39
9
R
55
-2
F
38
4
IRM
33
5
ACN
54
2
IVZ
42
13
MAS
46
3
EOG
28
2
GOOG
77
14
ZBH
69
15
OMC
37
2
CMI
49
2
FCX
44
4
EIX
61
8
CRM
65
6
TGT
35
4
CHD
34
7
SYF
78
7
MA
60
5
GE
60
5
NEE
39
9
R
55
-2
F
38
4
IRM
33
5
ACN
54
2
IVZ
42
13
MAS
46
3
EOG
28
2
GOOG
77
14
ZBH
69
15
OMC
37
2
CMI
49
2
FCX
44
4
EIX
61
8
CRM
65
6
TGT
35
4
Financhill
Back

Theravance Biopharma Vs. Nukkleus Industry Stock Comparison

Buy
51

TBPH
Theravance Biopharma

Last Price:
$9.62
Seasonality Move:
0.44%
Sell
46

NUKK
Nukkleus

Last Price:
$40.15
Seasonality Move:
-21.57%
Buy
51
Theravance Biopharma (TBPH) is a Buy

Is Theravance Biopharma a Buy, Sell or Hold?

  • The current Theravance Biopharma [TBPH] share price is $9.60. The Score for TBPH is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • TBPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $40.00. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TBPH Stock Price Chart

What is Theravance Biopharma's stock price today?

  • The Theravance Biopharma share price today is $9.60
    The current trend is moderately bearish and TBPH is experiencing selling pressure, which indicates risk of future bearish movement.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $40.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight selling pressure.

TBPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.16 Buy
Relative Strength Index (14 RSI): 50.37 Buy
Chaikin Money Flow: -218313 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.47 - 9.95) Sell
Bollinger Bands (100): (7.98 - 9.44) Buy

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.69 Buy
Relative Strength Index (14 RSI): 77.28 Buy
Chaikin Money Flow: -1366926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-7.5 - 22.6) Buy
Bollinger Bands (100): (-4.22 - 11.5) Buy

TBPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.83 Sell
20-day SMA: 9.71 Sell
50-day SMA: 9.18 Buy
200-day SMA: 8.9 Buy
8-day EMA: 9.77 Sell
20-day EMA: 9.68 Sell
50-day EMA: 9.31 Buy
200-day EMA: 9.06 Buy

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.07 Buy
20-day SMA: 9 Buy
50-day SMA: 4.99 Buy
200-day SMA: 4.78 Buy
8-day EMA: 26.51 Buy
20-day EMA: 14.21 Buy
50-day EMA: 7.47 Buy
200-day EMA: 11.77 Buy

Theravance Biopharma Earnings Growth & TBPH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.33 per share, and an increase next year of $1.08 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Theravance Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):